Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. MRX
MRX logo

MRX Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
66.600
Open
65.470
VWAP
63.67
Vol
914.41K
Mkt Cap
4.50B
Low
61.900
Amount
58.22M
EV/EBITDA(TTM)
13.84
Total Shares
71.93M
EV
6.68B
EV/OCF(TTM)
--
P/S(TTM)
1.66
Marex Group plc offers a diversified global financial services platform providing essential liquidity, market access and infrastructure services to clients across energy, commodities and financial markets. Its segments include Clearing, Agency and Execution, Market Making, Hedging and Investment Solutions, and Corporate. The Clearing segment acts as the interface between exchanges and clients. This segment provides the connectivity that allows its clients access to exchanges and central clearing houses. The Agency and Execution provide essential liquidity and execution services to its clients primarily in the energy and financial securities markets. Market Making segment acts as principal to provide direct market pricing to professional and wholesale counterparties, primarily within the metals, agriculture, energy and financial securities markets. It is also liquidity provider in both physical and derivatives markets across base metals, ferrous metals, energy and power.
Show More

Events Timeline

(ET)
2026-06-02
13:30:00
Cboe, CME Group, and Intercontinental Exchange Shares Drop Amid Competition Concerns
select
2026-06-02
12:20:00
CFTC Approves Kalshi to Offer Bitcoin Perpetual Futures
select
2026-06-01 (ET)
2026-06-01
07:10:00
Marex Group Acquires Levmet
select
2026-05-06 (ET)
2026-05-06
07:50:00
Group CEO Reports Q1 Revenue of $692.3M
select

News

Newsfilter
4.5
07-01Newsfilter
Marex Group Completes Redomiciliation to Bermuda
  • Redomiciliation Completed: Marex Group successfully completed its redomiciliation from England and Wales to Bermuda on July 1, 2026, effective at 8:41 AM London time, marking a significant structural adjustment for the company.
  • Shareholder Approval: The redomiciliation was supported by shareholders during meetings held on May 21, 2026, followed by global regulatory approvals and the sanction of the scheme by the English High Court on June 26, 2026, ensuring a smooth transition.
  • Structural Optimization: CEO Ian Lowitt stated that the move is expected to rationalize the corporate structure and regulatory framework, delivering cost savings and efficiencies that align with its Nasdaq listing requirements.
  • Future Outlook: While the redomiciliation presents numerous potential benefits, the company cautions investors about future risks and uncertainties, emphasizing that these forward-looking statements do not guarantee future performance.
Newsfilter
5.0
06-08Newsfilter
Marex Group Appoints New Board Member
  • New Board Appointment: Marex Group has appointed Georges Assi to its Board, effective immediately, where he will serve on the Risk Committee, expected to bring fresh perspectives and strategic direction to the company.
  • Fintech Expertise: Georges is the CEO of Sigma Lending, a fintech company he founded in 2023 that focuses on providing technology-enabled working capital solutions to UK SMEs, likely driving innovation within Marex's fintech initiatives.
  • Investment Banking Experience: Prior to joining Marex, Georges served as Senior Managing Director at Nomura International, overseeing global credit operations, and his extensive investment banking background is anticipated to enhance Marex's competitive edge in the market.
  • Strategic Growth Potential: Marex Board Chair Robert Pickering noted that Georges' entrepreneurial success and expertise in financial markets will create opportunities for innovation and growth, further solidifying Marex's position as a leading global financial services platform.
seekingalpha
8.5
06-01seekingalpha
Marex Group Acquires Levmet to Enhance Market Capabilities
  • Acquisition Announcement: Marex Group has announced the acquisition of liquidity provider Levmet, which, while undisclosed in terms, significantly enhances its market-making capabilities across base metals, energy, and power sectors.
  • Market Expansion: This acquisition extends Marex's financial services platform into European power and gas trading, thereby increasing its competitive edge in diversified markets.
  • Financial Performance: Marex Group's Q1 2026 earnings report indicates that it expects to maintain profit margins in the mid-20s over the next three years, suggesting robust financial performance post-acquisition.
  • Strategic Goals: Marex plans to redomicile in Bermuda in the second half of 2026, aiming to enhance its global market competitiveness through structural optimization.
Newsfilter
8.5
05-07Newsfilter
Marex Group Initiates Consent Solicitation for Bond Amendments
  • Consent Solicitation: Marex Group is soliciting consents from holders of its 6.404% Senior Notes due 2029 to amend the Indenture, aiming to align with the terms of the newly issued 2031 Notes, thereby enhancing the flexibility and attractiveness of its debt structure.
  • Cash Incentive: Holders who submit their consents by the expiration date will receive a cash payment of $1.00 per $1,000 principal amount of Notes, a strategy designed to boost participation in the amendments and ensure the requisite majority consents are obtained smoothly.
  • Redomiciliation Strategy: Marex plans to change its parent company's legal domicile from England and Wales to Bermuda, aiming to simplify corporate structure and reduce administrative costs, which will help enhance shareholder value and strengthen market competitiveness.
  • Future Outlook: If the necessary shareholder and regulatory approvals are obtained, Marex is expected to become a wholly-owned subsidiary of the new Bermuda parent company, which is anticipated to further optimize its listing on Nasdaq, enhance investor confidence, and drive future growth.
seekingalpha
9.5
05-07seekingalpha
Marex Group Reports Record Q1 2026 Earnings Driven by High Volatility
  • Significant Revenue Growth: Marex Group's Q1 2026 revenue surged 48% year-over-year to $692 million, with adjusted profit before tax rising 59% to $153 million, reflecting the company's robust performance amid high trading volumes and market volatility, thereby solidifying its market position.
  • Client Base Expansion: CEO Ian Lowitt highlighted that increases in customer balances and new client acquisitions were key drivers of performance, particularly in clearing and market-making segments, indicating the company's ongoing enhancement of market competitiveness and client appeal.
  • Capital Benefit Expectations: Marex anticipates closing the sale of Winterflood's custody business in Q2, which is expected to generate around $40 million in capital benefits, further strengthening the company's financial flexibility and capital structure.
  • Optimistic Future Outlook: Management expressed confidence in maintaining profitability levels between $38 million and $78 million in the coming months, with a medium-term target to elevate margins to the mid-20% range, demonstrating the company's commitment to sustained growth.
seekingalpha
9.5
05-06seekingalpha
Marex Group Reports Strong Q1 Earnings Beat
  • Earnings Beat: Marex Group reported a Q1 GAAP EPS of $1.52, exceeding expectations by $0.13, indicating robust profitability and operational efficiency.
  • Significant Revenue Growth: The company achieved revenues of $692.3 million in Q1, reflecting a 48.1% year-over-year increase, which not only surpassed analyst estimates by $31.02 million but also highlights a strong market recovery.
  • Increased Market Confidence: The impressive performance of Marex Group enhances investor confidence in its future growth potential, likely attracting more institutional investors and driving stock price appreciation.
  • Strategic Development Outlook: With improved revenue and profitability, Marex Group may increase investments in new markets and products to solidify its competitive position in the financial services sector.
Wall Street analysts forecast MRX stock price to rise
5 Analyst Rating
Wall Street analysts forecast MRX stock price to rise
5 Buy
0 Hold
0 Sell
Strong Buy
Current: 0.000
sliders
Low
49.00
Averages
51.00
High
54.00
Current: 0.000
sliders
Low
49.00
Averages
51.00
High
54.00
Barclays
NULL
to
Overweight
maintain
$55 -> $60
AI Analysis
2026-05-11
Reason
Barclays
Price Target
$55 -> $60
AI Analysis
2026-05-11
maintain
NULL
to
Overweight
Reason
Barclays raised the firm's price target on Marex Group to $60 from $55 and keeps an Overweight rating on the shares.
Goldman Sachs
Buy
maintain
$51 -> $62
2026-05-08
Reason
Goldman Sachs
Price Target
$51 -> $62
2026-05-08
maintain
Buy
Reason
Goldman Sachs raised the firm's price target on Marex Group to $62 from $51 and keeps a Buy rating on the shares.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for MRX
Unlock Now

Valuation Metrics

The current forward P/E ratio for Marex UK Holdings Ltd (MRX.O) is 8.76, compared to its 5-year average forward P/E of 9.29. For a more detailed relative valuation and DCF analysis to assess Marex UK Holdings Ltd's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PE
9.29
Current PE
8.76
Overvalued PE
10.86
Undervalued PE
7.72

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
16.03
Current EV/EBITDA
30.68
Overvalued EV/EBITDA
24.86
Undervalued EV/EBITDA
7.20

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
1.29
Current PS
1.70
Overvalued PS
1.53
Undervalued PS
1.06

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

what is the next 10 bagger?
Intellectia · 76 candidates
Market Cap: <= 5.00BRevenue Ttm: >= 50.00MQuarter Revenue Yoy Growth: >= 15.0%Market Cap Category: small, midQuarter Eps Yoy Growth: >= 15.0%Gross Margin: >= 25.00Relative Vol: >= 1.20Moving Average Relationship: PriceAboveMA20, PriceAboveMA200
Ticker
Name
Market Cap$
top bottom
UROY logo
UROY
Uranium Royalty Corp
602.50M
HRZN logo
HRZN
Horizon Technology Finance Corp
312.64M
NUVB logo
NUVB
Nuvation Bio Inc
1.75B
BCRX logo
BCRX
BioCryst Pharmaceuticals Inc
2.24B
ZVRA logo
ZVRA
Zevra Therapeutics Inc
665.04M
ESPR logo
ESPR
Esperion Therapeutics Inc
810.91M
most bullish ticker
Intellectia · 46 candidates
Analyst Consensus: Strong BuyTarget Price Upside Potential: MoreAbovePriceMoving Average Relationship: PriceAboveMA200Option Sentiments: BullishOne Week Rise Prob: >= 70
Ticker
Name
Market Cap$
top bottom
TARS logo
TARS
Tarsus Pharmaceuticals Inc
2.78B
DERM logo
DERM
Journey Medical Corp
276.86M
CYTK logo
CYTK
Cytokinetics Inc
7.93B
ABCL logo
ABCL
Abcellera Biologics Inc
1.19B
SVRA logo
SVRA
Savara Inc
1.16B
TSHA logo
TSHA
Taysha Gene Therapies Inc
1.29B

Whales Holding MRX

G
Granahan Investment Management, LLC
Holding
MRX
+33.85%
3M Return
P
Portolan Capital Management, LLC
Holding
MRX
+32.07%
3M Return
R
Royce & Associates, LP
Holding
MRX
+12.93%
3M Return
S
Samlyn Capital, LLC
Holding
MRX
+11.69%
3M Return
N
North Reef Capital Management LP
Holding
MRX
+3.64%
3M Return
S
Seven Grand Managers LLC
Holding
MRX
-3.90%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Marex UK Holdings Ltd (MRX) stock price today?

The current price of MRX is 62.52 USD — it has decreased -4.14

What is Marex UK Holdings Ltd (MRX)'s business?

Marex Group plc offers a diversified global financial services platform providing essential liquidity, market access and infrastructure services to clients across energy, commodities and financial markets. Its segments include Clearing, Agency and Execution, Market Making, Hedging and Investment Solutions, and Corporate. The Clearing segment acts as the interface between exchanges and clients. This segment provides the connectivity that allows its clients access to exchanges and central clearing houses. The Agency and Execution provide essential liquidity and execution services to its clients primarily in the energy and financial securities markets. Market Making segment acts as principal to provide direct market pricing to professional and wholesale counterparties, primarily within the metals, agriculture, energy and financial securities markets. It is also liquidity provider in both physical and derivatives markets across base metals, ferrous metals, energy and power.

What is the price predicton of MRX Stock?

Wall Street analysts forecast MRX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MRX is51.00 USD with a low forecast of 49.00 USD and a high forecast of 54.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Marex UK Holdings Ltd (MRX)'s revenue for the last quarter?

Marex UK Holdings Ltd revenue for the last quarter amounts to 908.70M USD, increased 48.31

What is Marex UK Holdings Ltd (MRX)'s earnings per share (EPS) for the last quarter?

Marex UK Holdings Ltd. EPS for the last quarter amounts to 1.52 USD, increased 55.10

How many employees does Marex UK Holdings Ltd (MRX). have?

Marex UK Holdings Ltd (MRX) has 3109 emplpoyees as of July 05 2026.

What is Marex UK Holdings Ltd (MRX) market cap?

Today MRX has the market capitalization of 4.50B USD.